Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Adaptive Biotechnologies Corp (NASDAQ: ADPT) was $3.11 for the day, down -3.42% from the previous closing price of $3.22. In other words, the price has decreased by -$3.42 from its previous closing price. On the day, 1.11 million shares were traded. ADPT stock price reached its highest trading level at $3.28 during the session, while it also had its lowest trading level at $3.1.
Ratios:
Our analysis of ADPT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.50 and its Current Ratio is at 4.66. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.71.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’24 when ROBINS CHAD M sold 48,673 shares for $3.43 per share. The transaction valued at 167,007 led to the insider holds 2,576,701 shares of the business.
RUBINSTEIN JULIE sold 39,070 shares of ADPT for $135,764 on Mar 05 ’24. The President now owns 472,754 shares after completing the transaction at $3.47 per share. On Mar 05 ’24, another insider, BENZENO SHARON, who serves as the Chief Commercial Ofc Imm Med of the company, sold 29,390 shares for $3.44 each. As a result, the insider received 100,994 and left with 327,415 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 458314464 and an Enterprise Value of 334146976. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.69 while its Price-to-Book (P/B) ratio in mrq is 1.46. Its current Enterprise Value per Revenue stands at 1.962 whereas that against EBITDA is -1.863.
Stock Price History:
Over the past 52 weeks, ADPT has reached a high of $9.08, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is -0.43%, while the 200-Day Moving Average is calculated to be -32.40%.
Shares Statistics:
ADPT traded an average of 1.73M shares per day over the past three months and 1489070 shares per day over the past ten days. A total of 145.08M shares are outstanding, with a floating share count of 140.68M. Insiders hold about 4.54% of the company’s shares, while institutions hold 92.20% stake in the company. Shares short for ADPT as of 1713139200 were 10005472 with a Short Ratio of 5.78, compared to 1710460800 on 8457164. Therefore, it implies a Short% of Shares Outstanding of 10005472 and a Short% of Float of 8.72.
